A new neuron-nourishing protein that may prove useful for treating Parkinson's disease is revealed in a paper published in Nature.
Parkinson's disease destroys nerve cells that produce the neurotransmitter dopamine, leading to movement and balance problems. The new molecule, dubbed conserved dopamine neurotrophic factor (CDNF), can prevent the degeneration of dopamine-producing neurons in a rat model of Parkinson's disease. But Mart Saarma and colleagues go one step further, showing that CDNF actually stops ongoing cell death and can help damaged dopaminergic neurons to recover, easing symptoms in their animal model.
Current anti-Parkinsonian drugs do not prevent neuronal degeneration and death, and their effects can be patchy and short-lived. The results suggest that CDNF has great potential as a therapeutic protein for Parkinson's disease.
Mart Saarma (University of Helsinki, Finland)
(C) Nature press release.
Message posted by: Trevor M. D'Souza
Bookmark and Share this page (what is this?)
Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.
Use the links below to share this article on the social bookmarking site of your choice.
Read more about social bookmarking at Wikipedia - Social Bookmarking